AGC Pharma Chemicals opens new €100 million manufacturing plant in Spain
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal phase III IMforte study
Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder for concentrate for solution for infusion is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
Subscribe To Our Newsletter & Stay Updated